Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

SpaceX IPO could make Elon Musk the first trillionaire but faces major volatility risks, analyst warns.

Market News
18 May 2026
Forbes
View Source
Neutral
pluang ai news

SpaceX is set for a historic IPO expected around June 12, potentially valuing the company at $1.75 trillion and raising $75 billion. This debut could make Elon Musk the world's first trillionaire due to his 43% stake. However, analysts warn of significant volatility and downside risks, partly due to Musk's outsized voting power and ambitious projects like Mars colonization that may not prioritize shareholder returns. The IPO's success will be influenced by investor optimism about SpaceX's cost-effective satellite launches compared to competitors, but the stock could experience wild swings similar to Tesla's history.

More News

Audiencerate appoints Riccardo Fabbri as CTO to lead AI-driven platform expansion for SMEs and media agencies.

Audiencerate appoints Riccardo Fabbri as CTO to lead AI-driven platform expansion for SMEs and media agencies.

Audiencerate Ltd has named Riccardo Fabbri as its new Chief Technology Officer, marking the start of an AI-driven expansion phase for its platforms serving Italian SMEs and global media agencies. Fabbri, with over 20 years of experience in software a...

Company Fundamentals
Bullish
1 hour ago
Biogen and Denali halt BIIB122 development after Phase 2b Parkinson's study fails to meet endpoints

Biogen and Denali halt BIIB122 development after Phase 2b Parkinson's study fails to meet endpoints

Biogen and Denali announced that their Phase 2b LUMA study of BIIB122 (DNL151) in early-stage Parkinson's disease did not meet its primary or secondary endpoints, showing no slowing of disease progression compared to placebo. Despite good safety and ...

Company Fundamentals
Bearish
2 hours ago
Biogen and Denali halt BIIB122 development after Phase 2b study fails to slow early Parkinson's progression

Biogen and Denali halt BIIB122 development after Phase 2b study fails to slow early Parkinson's progression

Biogen and Denali announced that their Phase 2b LUMA study of BIIB122, a drug targeting early-stage Parkinson's disease, did not meet its primary or secondary endpoints, showing no slowing of disease progression compared to placebo. Despite good safe...

Market News
Bearish
2 hours ago
Samba TV launches Project Gravity, a platform for real-time data activation across major ad platforms.

Samba TV launches Project Gravity, a platform for real-time data activation across major ad platforms.

Samba TV has introduced Project Gravity, an independent data onboarding and activation platform that integrates advertisers' first-party data with over 40 leading advertising platforms like Google DV360, Meta, and TikTok. Designed for the agentic era...

Others
Bullish
2 hours ago
IMAX shares jump as company explores potential sale amid growing market share.

IMAX shares jump as company explores potential sale amid growing market share.

IMAX is reportedly exploring a potential sale, approaching entertainment firms, though talks are early and may not lead to a deal. The company has seen strong growth, with its premium large-format theaters increasing their share of U.S. and Canadian ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App